Nasopharyngeal carcinoma causes

Jump to navigation Jump to search

Nasopharyngeal carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nasopharyngeal carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nasopharyngeal carcinoma causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nasopharyngeal carcinoma causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nasopharyngeal carcinoma causes

CDC on Nasopharyngeal carcinoma causes

Nasopharyngeal carcinoma causes in the news

Blogs on Nasopharyngeal carcinoma causes

Directions to Hospitals Treating Nasopharyngeal carcinoma

Risk calculators and risk factors for Nasopharyngeal carcinoma causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]

Overview

Common causes of nasopharyngeal carcinoma include Epstein Barr virus (EBV infection), Human Papillomavirus (HPV infection), and consumption of salted fish as a source of N-nitrosamine.

Causes

Common Causes

Common causes of nasopharyngeal carcinoma may include:

EBV infection is perhaps the most extensively studied

aetiological factor for nasopharyngeal carcinoma. On the

basis of in-situ hybridisation techniques to EBV-encoded

RNAs, the virus is detected exclusively in all tumour cells

but not in normal nasopharyngeal epithelium, suggesting

that EBV activation is necessary in the pathogenesis of

nasopharyngeal carcinoma. This notion is further

supported by reports that similar techniques undertaken

on preinvasive lesions identifi ed the presence of EBV even

during the initial phases of malignant transformation.6,7

Yet, the inability to detect EBV in nasopharyngeal biopsy

samples from high-risk individuals suggests that other

factors are needed for the EBV-infected epithelial cell to

undergo malignant transformation. Recent work has

proposed that deregulation of cell-cycle checkpoint

through p16 inactivation and cyclin D1 overexpression

promotes maintenance of the viral genome, favouring

transition of low-grade dysplasia to higher grade lesions.8,9

Intrinsic genetic determinants such as 3p and 9p deletions

have also been suggested as mechanisms of susceptibility

to EBV infection and its downstream eff ects.10 Epigenetic

modifi cations that are associated with a tumorigenic

phenotype have been identifi ed in EBV-infected epithelial

cells and were shown to persist even in the absence of the

virus (appendix).

References

Template:WH Template:WS